Kodak PCR patent
This article was originally published in The Gray Sheet
Executive Summary
Eastman Kodak says it will receive a patent on a method for performing polymerase chain reaction diagnosis. The Kodak method "isolates each test within a disposable reaction enclosure, or 'PCR pouch,' with blister-like compartments containing the necessary chemical reagents for various steps," the company explains. The system "is based on proprietary dyes used in other Kodak test kits, and results are available within a few hours." The method "will significantly widen Kodak's future offerings in in vitro diagnostics," the company says. Kodak recently licensed "key" PCR patients from Roche as part of a patent rights dispute settlement ("The Gray Sheet" June 7, I&W-3).